Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 15, 2019 - Issue 12
Submit an article Journal homepage
3,167
Views
6
CrossRef citations to date
0
Altmetric
Research Paper

Assessment of population immunity to measles in Ontario, Canada: a Canadian Immunization Research Network (CIRN) study

Shelly Bolotina Public Health Ontario, Toronto, ON, Canada;b Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada;c Dalla Lana School of Public Health, University of Toronto, Toronto, ON, CanadaCorrespondence[email protected]
View further author information
,
Alberto Severinid National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada;e Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB, CanadaView further author information
,
Todd Hatchettef Department of Pathology and Laboratory Medicine, Nova Scotia Health Authority, Halifax, NS, Canada;g Department of Pathology, Dalhousie University, Halifax, NS, CanadaORCID Iconhttps://orcid.org/0000-0002-5377-2528View further author information
ORCID Icon,
Elizabeth McLachland National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, CanadaORCID Iconhttps://orcid.org/0000-0001-6967-794XView further author information
ORCID Icon,
Rachel Savagea Public Health Ontario, Toronto, ON, CanadaView further author information
,
Stephanie L. Hughesa Public Health Ontario, Toronto, ON, CanadaORCID Iconhttps://orcid.org/0000-0002-6708-3731View further author information
ORCID Icon,
John Wanga Public Health Ontario, Toronto, ON, CanadaView further author information
,
Shelley L. Deeksa Public Health Ontario, Toronto, ON, Canada;c Dalla Lana School of Public Health, University of Toronto, Toronto, ON, CanadaView further author information
,
Sarah Wilsona Public Health Ontario, Toronto, ON, Canada;c Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada;h ICES, Toronto, ON, CanadaORCID Iconhttps://orcid.org/0000-0002-8239-0094View further author information
ORCID Icon,
Marc Brissoni Département de médecine sociale et préventive, Université Laval, Québec City, QC, CanadaView further author information
,
Scott A. Halpering Department of Pathology, Dalhousie University, Halifax, NS, Canada;j Canadian Center for Vaccinology, IWK Health Centre, Halifax, NS, CanadaView further author information
,
Jonathan Gubbaya Public Health Ontario, Toronto, ON, Canada;b Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, CanadaView further author information
,
Tony Mazzullia Public Health Ontario, Toronto, ON, Canada;b Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada;k Department of Microbiology, Mount Sinai Hospital, Toronto, ON, CanadaView further author information
,
Bouchra Serhirl Laboratoire de santé publique du Québec/Institut national de santé publique du Québec, Sainte-Anne-de-Bellevue, QC, CanadaORCID Iconhttps://orcid.org/0000-0003-0735-0452View further author information
ORCID Icon,
Brian J. Wardm Department of Microbiology and Immunology, McGill University, Montreal, QC, Canada;n Research Institute of the McGill University Health Centre, Montreal, QC, CanadaORCID Iconhttps://orcid.org/0000-0003-3251-958XView further author information
ORCID Icon &
Natasha Crowcrofta Public Health Ontario, Toronto, ON, Canada;b Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada;c Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada;h ICES, Toronto, ON, CanadaORCID Iconhttps://orcid.org/0000-0002-6761-8783View further author information
ORCID Icon show all
Pages 2856-2864 | Received 07 Jan 2019, Accepted 07 May 2019, Published online: 16 Jul 2019

References

  • Anderson RM, May RM. Infectious diseases of humans: dynamics and control. Oxford, New York: Oxford University Press; 2010.
  • King A, Varughese P, De Serres G, Tipples GA, Waters J. Working group on measles elimination. Measles elimination in Canada. J Infect Dis. 2004;189:S236–42.
  • Dabbagh A, Patel MK, Dumolard L, Gacic-Dobo M, Mulders MN, Okwo-Bele JM, Kretsinger K, Papania MJ, Rota PA, Goodson JL. Progress toward regional measles elimination - worldwide, 2000–2016. MMWR Morb Mortal Wkly Rep. 2017;66:1148–53. doi:10.15585/mmwr.mm6642a6.
  • Fine PE. Herd immunity: history, theory, practice. Epidemiol Rev. 1993;15:265–302. doi:10.1093/oxfordjournals.epirev.a036121.
  • Durrheim DN. Measles elimination, immunity, serosurveys and other immunity gap diagnostic tools. J Infect Dis. 2018;218:341–43. doi:10.1093/infdis/jiy138.
  • Guerra FM, Bolotin S, Lim G, Heffernan J, Deeks SL, Li Y, Crowcroft NS. The basic reproduction number (R0) of measles: A systematic review. Lancet Infect Dis. 2017;17:e420–e428. doi:10.1016/S1473-3099(17)30307-9.
  • Public Health Agency of Canada. Vaccination coverage goals and vaccine preventable disease reduction targets by 2025; 2017. [accessed 2018 Oct 5] https://www.canada.ca/en/public-health/services/immunization-vaccine-priorities/national-immunization-strategy/vaccination-coverage-goals-vaccine-preventable-diseases-reduction-targets-2025.html#1.1.3;.
  • Pan American Health Organization (PAHO), World Health Organization (WHO) Regional Office for the Americas. 29th Pan American Sanitary Conference. 69th session of the Regional Committee of WHO for the Americas. Washington (DC): Pan American Health Organization. 2017 Sep 25–29. Final Report.
  • Dimech W, Mulders MN. A 16-year review of seroprevalence studies on measles and rubella. Vaccine. 2016;34:4110–18. doi:10.1016/j.vaccine.2016.06.002.
  • Public Health Agency of Canada (PHAC). Canadian immunization guide, Part 4, active vaccines, measles vaccines. Ottawa (ON): Government of Canada; 2015.
  • Government of Canada. Canada’s provincial and territorial routine (and catch-up) vaccination programs for infants and children. 2018. [accessed 2019 May 27] https://www.canada.ca/en/public-health/services/provincial-territorial-immunization-information/provincial-territorial-routine-vaccination-programs-infants-children.html
  • Wilson SE, Quach S, MacDonald SE, Naus M, Deeks SL, Crowcroft NS, Mahmud SM, Tran D, Kwong JC, Tu K. Immunization information systems in Canada: attributes, functionality, strengths and challenges. A Canadian immunization research network study. Can J Public Health. 2017;107:575–82. doi:10.17269/CJPH.107.5679.
  • Ontario Agency for Health Protection and Promotion (Public Health Ontario). Immunization coverage report for school pupils in Ontario: 2013–14, 2014–15 and 2015–16 School Years. Toronto: Queen’s Printer for Ontario; 2017.
  • Ng E, Sanmartin C, Elien-Massenat D, Manuel DG. Vaccine-preventable disease-related hospitalization among immigrants and refugees to Canada: study of linked population-based databases. Vaccine. 2016;34:4437–42. doi:10.1016/j.vaccine.2016.06.079.
  • Greenaway C, Dongier P, Boivin JF, Tapiero B, Miller M, Schwartzman K. Susceptibility to measles, mumps, and rubella in newly arrived adult immigrants and refugees. Ann Intern Med. 2007;146:20–24.
  • Ontario Ministry of Finance. Office of economic policy labour and demographic analysis branch. 2011 National household survey highlights. Vol. 2018. 2013. p. 2. [accessed 2018 Oct 18] https://www.fin.gov.on.ca/en/economy/demographics/census/nhshi11-1.html
  • Seagle EE, Bednarczyk RA, Hill T, Fiebelkorn AP, Hickman CJ, Icenogle JP, Belongia EA, McLean HQ. Measles, mumps, and rubella antibody patterns of persistence and rate of decline following the second dose of the MMR vaccine. Vaccine. 2018;36:818–26. doi:10.1016/j.vaccine.2017.12.075.
  • Vyse AJ, Gay NJ, Hesketh LM, Pebody R, Morgan-Capner P, Miller E. Interpreting serological surveys using mixture models: the seroepidemiology of measles, mumps and rubella in England and Wales at the beginning of the 21st century. Epidemiol Infect. 2006;134:1303–12. doi:10.1017/S0950268806006340.
  • Canadian Public Health Association. Immunization timeline; 2018. [accessed 2018 Apr 26] https://www.cpha.ca/immunization-timeline.
  • Public Health Agency of Canada. Vaccine coverage in canadian children: results from the 2013 childhood national immunization coverage survey (CNICS). Ottawa, ON: Public Health Agency of Canada; 2016.
  • Ontario Agency for Health Protection and Promotion (Public Health Ontario). Immunization coverage report for school pupils in Ontario: 2016–17 School year. Toronto: Queen’s Printer for Ontario; 2018.
  • Ontario Agency for Health Protection and Promotion (Public Health Ontario). Immunization coverage report for school pupils: 2012–13 School year. Toronto: Queen’s Printer for Ontario; 2014.
  • Ontario Ministry of Health and Long-Term Care, Public Health Division. Immunization coverage report for school pupils - school years 2004/05 to 2007/08. Queen’s printer for Ontario; 2009.
  • Whittle H, Aaby P, Samb B, Cisse B, Kanteh F, Soumare M, Jensen H, Bennett J, Simondon F. Poor serologic responses five to seven years after immunization with high and standard titer measles vaccines. Pediatr Infect Dis J. 1999;18:53–57.
  • World Health Organization (WHO). The immunological basis for immunization series module 7: measles. Geneva, CH: WHO Press; 2009.
  • Green MS, Shohat T, Lerman Y, Cohen D, Slepon R, Duvdevani P, Varsano N, Dagan R, Mendelson E. Sex differences in the humoral antibody response to live measles vaccine in young adults. Int J Epidemiol. 1994;23:1078–81. doi:10.1093/ije/23.5.1078.
  • Gidding HF, Quinn HE, Hueston L, Dwyer DE, McIntyre PB. Declining measles antibodies in the era of elimination: Australia’s experience. Vaccine. 2018;36:507–13. doi:10.1016/j.vaccine.2017.12.002.
  • Lebo EJ, Kruszon-Moran DM, Marin M, Bellini WJ, Schmid S, Bialek SR, Wallace GS, McLean HQ. Seroprevalence of measles, mumps, rubella and varicella antibodies in the United States population, 2009–2010. Open Forum Infect Dis. 2015;(2):ofv006. doi:10.1093/ofid/ofv006.
  • Bautista-Lopez N, Ward BJ, Mills E, McCormick D, Martel N, Ratnam S. Development and durability of measles antigen-specific lymphoproliferative response after MMR vaccination. Vaccine. 2000;18:1393–401.
  • Thomas S, Hiebert J, Gubbay JB, Gournis E, Sharron J, Severini A, Jiaravuthisan M, Shane A, Jaeger V, Crowcroft NS, et al. Measles outbreak with unique virus genotyping, Ontario, Canada, 2015. Emerg Infect Dis. 2017;23:1063–69. doi:10.3201/eid2307.161145.
  • Leuridan E, Hens N, Hutse V, Ieven M, Aerts M, Van Damme P. Early waning of maternal measles antibodies in era of measles elimination: longitudinal study. BMJ. 2010;340:c1626. doi:10.1136/bmj.c293.
  • Kelly H, Riddell MA, Gidding HF, Nolan T, Gilbert GL. A random cluster survey and a convenience sample give comparable estimates of immunity to vaccine preventable diseases in children of school age in Victoria, Australia. Vaccine. 2002;20:3130–36.
  • Wilson SE, Khan K, Gilca V, Miniota J, Deeks SL, Lim G, Eckhardt R, Bolotin S, Crowcroft NS. Global travel patterns and risk of measles in Ontario and Quebec, Canada: 2007–2011. BMC Infect Dis. 2015;15:341–015–1039–0. doi:10.1186/s12879-015-1039-0.
  • Statistics Canada. Census profile, 2016 census. 2017. Statistics Canada Catalogue no. 98-316-X2016001.
  • Chen RT, Markowitz LE, Albrecht P, Stewart JA, Mofenson LM, Preblud SR, Orenstein WA. Measles antibody: reevaluation of protective titers. J Infect Dis. 1990;162:1036–42. doi:10.1093/infdis/162.5.1036.
  • Sowers SB, Rota JS, Hickman CJ, Mercader S, Redd S, McNall RJ, Williams N, McGrew M, Walls ML, Rota PA, et al. High concentrations of measles neutralizing antibodies and high-avidity measles IgG accurately identify measles reinfection cases. Clin Vaccine Immunol. 2016;23:707–16. doi:10.1128/CVI.00268-16.
  • Kontio M, Jokinen S, Paunio M, Peltola H, Davidkin I. Waning antibody levels and avidity: implications for MMR vaccine-induced protection. J Infect Dis. 2012;206:1542–48. doi:10.1093/infdis/jis568.
  • Funk S, Knapp J, Lebo E, Reef S, Dabbagh A, Kretsinger K, Jit M, Edmunds WJ, Strebel PM. Target immunity levels for achieving and maintaining measles elimination. bioRxiv. 2017;201574. http://dx.doi.org/10.1101/201574
  • de Melker H, Pebody RG, Edmunds WJ, Levy-Bruhl D, Valle M, Rota MC, Salmaso S, van Den Hof S, Berbers G, Saliou P, et al. The seroepidemiology of measles in Western Europe. Epidemiol Infect. 2001;126:249–59.
  • Del Fava E, Shkedy Z, Bechini A, Bonanni P, Manfredi P. Towards measles elimination in italy: monitoring herd immunity by Bayesian mixture modelling of serological data. Epidemics. 2012;4:124–31. doi:10.1016/j.epidem.2012.05.001.
  • Tischer A, Andrews N, Kafatos G, Nardone A, Berbers G, Davidkin I, Aboudy Y, Backhouse J, Barbara C, Bartha K, et al. Standardization of measles, mumps and rubella assays to enable comparisons of seroprevalence data across 21 European countries and Australia. Epidemiol Infect. 2007;135:787–97. doi:10.1017/S0950268807008266.
  • Cohen BJ, Doblas D, Andrews N. Comparison of plaque reduction neutralisation test (PRNT) and measles virus-specific IgG ELISA for assessing immunogenicity of measles vaccination. Vaccine. 2008;26:6392–97. doi:10.1016/j.vaccine.2008.08.074.
  • Hatchette TF, Scholz H, Bolotin S, Crowcroft NS, Jackson C, McLachlan E, Severini A. Calibration and evaluation of quantitative antibody titers for measles virus by using the BioPlex 2200. Clin Vaccine Immunol. 2017;24:e00269–16. doi:10.1128/CVI.00269-16.
  • Canadian Immunization Research Network. Population immunity to measles in Canada; 2016. [accessed 2019 May 27] http://cirnetwork.ca/research-study/population-immunity-to-measles-in-canada/.
  • Statistics Canada C. Statistics canada. table 17- 10-0005-01.population estimates on July 1st, by age and sex. 2018. [accessed 2019 May 28] https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1710000501
  • Bentley M, Christian P, Heath A, National institute for biological standards and control. Report on a collaborative study to investigate the relationship between the 1st IRP and the 2nd and 3rd international standards for anti-measles Serum/ Plasma,in both ELISA and PRNT. Expert Committee on Biological Standardization 2007; WHO/BS.07/2076:1-17.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.